Abstract
An extensive range of molecular defects have been identified in the human mitochondrial genome (mtDNA), many associated with well-characterised, progressive neurological syndromes. Although point mutations within mitochondrial (mt-) tRNA genes are the commonest mtDNA defect observed, many of their inherent characteristics remain poorly understood. Determinants of clinical heterogeneity and hereditability are two features of mt-tRNA mutations which are clinically important in terms of prognosis and genetic counselling.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have